Camonsertib
Camonsertib is an oral serine/threonine kinase inhibitor from Hoffmann-La Roche, in registered phase 2 trials for metastatic cancer.
Overview
Camonsertib is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Hoffmann-La Roche, in metastatic cancer. A serine/threonine kinase inhibitor: the name stem -sertib marks a small molecule that blocks a kinase in this family. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
A serine/threonine kinase inhibitor: the name stem -sertib marks a small molecule that blocks a kinase in this family.
1.Camonsertib slips into a pocket on its target.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"Camonsertib" OR ABSTRACT:"Camonsertib") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Camonsertib, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentSelicrelumab
Shares Flatiron Health (Roche), Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentSamuraciclib
Shares Flatiron Health (Roche), Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentEVM14
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentHST-1011
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentIPG1094
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TrialA Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
Shares Flatiron Health (Roche), Metastatic cancer (cancer that has spread) and the tag pipeline.
- TreatmentEvexomostat
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentMerestinib
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.